Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis.
Nano- and Microformulations to Advance Therapies for Visceral Leishmaniasis.
复制标题
纳米和微制剂促进内脏利什曼病的治疗。
DOI:
10.1021/acsbiomaterials.0c01132
复制
发表时间:
2021-05-10
影响因子:
5.8
通讯作者:
Ainslie, Kristy M.
中科院分区:
文献类型:
--
作者:
Varma, Devika M.;Redding, Elizabeth A.;Bachelder, Eric M.;Ainslie, Kristy M.
关键词:
Visceral leishmaniasis (VL) is a deadly, vector-borne, neglected tropical disease endemic to arid parts of the world and is caused by a protozoan parasite of the genus Leishmania. Chemotherapy is the primary treatment for this systemic disease, and multiple potent therapies exist against this intracellular parasite. However, several factors, such as systemic toxicity, high costs, arduous treatment regimen, and rising drug resistance, are barriers for effective therapy against VL. Material-based platforms have the potential to revolutionize chemotherapy for leishmaniasis by imparting a better pharmacokinetic profile and creating patient-friendly routes of administration, while also lowering the risk for drug resistance. This review highlights promising drug delivery strategies and novel therapies that have been evaluated in preclinical models, demonstrating the potential to advance chemotherapy for VL.
登录
查看更多内容
影响因子:
8
作者:
Bruni N;Stella B;Giraudo L;Della Pepa C;Gastaldi D;Dosio F
通讯作者:
Dosio F
DOI:
10.1016/j.ejpb.2014.11.019
发表时间:
2015-01-01
影响因子:
4.9
作者:
Asthana, Shalini;Jaiswal, Anil K.;Chourasia, Manish K.
通讯作者:
Chourasia, Manish K.
影响因子:
4.9
作者:
Collier MA;Junkins RD;Gallovic MD;Johnson BM;Johnson MM;Macintyre AN;Sempowski GD;Bachelder EM;Ting JP;Ainslie KM
通讯作者:
Ainslie KM
影响因子:
4.9
作者:
Banerjee, Antara;De, Manjarika;Ali, Nahid
通讯作者:
Ali, Nahid
DOI:
10.1016/j.ejpb.2015.04.018
发表时间:
2015-06-01
影响因子:
4.9
作者:
Carvalheiro, Manuela;Alexandra Esteves, M.;Cruz, M. Eugenia M.
通讯作者:
Cruz, M. Eugenia M.